Patent Law

Abbott prevails on patent term extension for stent

By Lawrence B. Ebert, Esq.

Abbott is seeking to extend the patent until May 24, 2011, to account for time it took to research and win approval for its Xience stent, a tiny mesh scaffold used to prop open clogged arteries that went on sale in July. A review by the patent office, which announced the extension in a decision published Tuesday [Oct. 14], is continuing.

In a case in California, Medtronic had attempted to block the impact of the extension on an injunction against Medtronic.

See also
http://ipbiz.blogspot.com/2008/10/wyeth-v-dudas-on-patent-term.html

Full post as published by IPBiz on October 20, 2008 (boomark / email).